TY - JOUR
T1 - PET/CT Based Dose Planning in Radiotherapy
AU - Berthelsen, Anne Kiil
AU - Jakobsen, Annika Loft
AU - Sapru, Wendy
AU - Kristensen, Claus Andrup
AU - Christensen, Charlotte
AU - Roed, Henrik
AU - Højgaard, Liselotte
AU - Engelholm, Svend Aage
AU - Bjørk-Eriksson, Thomas
PY - 2011/8
Y1 - 2011/8
N2 - This mini-review describes how to perform PET/CT based radiotherapy dose planning and the advantages and possibilities obtained with the technique for radiation therapy. Our own experience since 2002 is briefly summarized from more than 2,500 patients with various malignant diseases undergoing radiotherapy planning with PET/CT prior to the treatment. The PET/CT, including the radiotherapy planning process as well as the radiotherapy process, is outlined in detail. The demanding collaboration between mould technicians, nuclear medicine physicians and technologists, radiologists and radiology technologists, radiation oncologists, physicists, and dosimetrists is emphasized. We strongly believe that PET/CT based radiotherapy planning will improve the therapeutic output in terms of target definition and non-target avoidance and will play an important role in future therapeutic interventions in many malignant diseases.
AB - This mini-review describes how to perform PET/CT based radiotherapy dose planning and the advantages and possibilities obtained with the technique for radiation therapy. Our own experience since 2002 is briefly summarized from more than 2,500 patients with various malignant diseases undergoing radiotherapy planning with PET/CT prior to the treatment. The PET/CT, including the radiotherapy planning process as well as the radiotherapy process, is outlined in detail. The demanding collaboration between mould technicians, nuclear medicine physicians and technologists, radiologists and radiology technologists, radiation oncologists, physicists, and dosimetrists is emphasized. We strongly believe that PET/CT based radiotherapy planning will improve the therapeutic output in terms of target definition and non-target avoidance and will play an important role in future therapeutic interventions in many malignant diseases.
U2 - 10.2174/157340511796411131
DO - 10.2174/157340511796411131
M3 - Review
SN - 1573-4056
VL - 7
SP - 210
EP - 215
JO - Current Medical Imaging Reviews
JF - Current Medical Imaging Reviews
IS - 3
ER -